The role of smoking and alcohol behaviour in the management of inflammatory bowel disease.

[1]  S. Fagoonee,et al.  Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy , 2018, Irish Journal of Medical Science (1971 -).

[2]  R. Cross,et al.  Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population , 2017, Digestive Diseases and Sciences.

[3]  E. Riboli,et al.  No association of alcohol use and the risk of ulcerative colitis or Crohn’s disease: data from a European Prospective cohort study (EPIC) , 2017, European Journal of Clinical Nutrition.

[4]  F. Bishehsari,et al.  Alcohol and Gut-Derived Inflammation , 2017, Alcohol research : current reviews.

[5]  G. Kaplan,et al.  Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration , 2016, BMC Gastroenterology.

[6]  K. Talavera,et al.  Transient Receptor Potential Channels in Intestinal Inflammation: What Is the Impact of Cigarette Smoking? , 2016, Pathobiology.

[7]  M. Bouin,et al.  Patients With Inflammatory Bowel Disease Are Unaware of the Impact of Smoking on Their Disease , 2016, Journal of clinical gastroenterology.

[8]  G. Kaplan,et al.  The Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis , 2016, Clinical and Translational Gastroenterology.

[9]  L. Lix,et al.  What Are Adults With Inflammatory Bowel Disease (IBD) Eating? A Closer Look at the Dietary Habits of a Population-Based Canadian IBD Cohort. , 2016, JPEN. Journal of parenteral and enteral nutrition.

[10]  M. Sans,et al.  Impact of Smoking Cessation on the Clinical Course of Crohn’s Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study , 2016, The American Journal of Gastroenterology.

[11]  A. Ford,et al.  Systematic review with meta‐analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease , 2016, Alimentary pharmacology & therapeutics.

[12]  C. Hollenbeak,et al.  Impact of smoking on the surgical outcome of Crohn's disease: a propensity‐score matched National Surgical Quality Improvement Program analysis , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[13]  L. Peyrin-Biroulet,et al.  Beliefs and behaviour about smoking among inflammatory bowel disease patients , 2015, European journal of gastroenterology & hepatology.

[14]  Sumant Inamdar,et al.  Smoking and early infliximab response in Crohn’s disease: a meta-analysis. , 2015, Journal of Crohn's & colitis.

[15]  F. Magro,et al.  Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies. , 2015, Journal of Crohn's & colitis.

[16]  S. Jafri,et al.  Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients , 2015, Digestive Diseases and Sciences.

[17]  I. Pinchuk,et al.  miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD , 2014, Gut.

[18]  S. Czachowski,et al.  Motivations toward smoking cessation, reasons for relapse, and modes of quitting: results from a qualitative study among former and current smokers , 2014, Patient preference and adherence.

[19]  E. Cabré,et al.  Optimizing post-operative Crohn’s disease treatment , 2014, Annals of gastroenterology.

[20]  N. Vergnolle.  TRPV4: new therapeutic target for inflammatory bowel diseases. , 2014, Biochemical pharmacology.

[21]  S. Ajmi,et al.  Suspected azathioprine induced liver cirrhosis: an unusual side effect , 2014, The Pan African medical journal.

[22]  H. Uhlig.  Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease , 2013, Gut.

[23]  J. Gisbert,et al.  Smoking does influence disease behaviour and impacts the need for therapy in Crohn′s disease in the biologic era , 2013, Alimentary pharmacology & therapeutics.

[24]  M. Long,et al.  A clinical review of recent findings in the epidemiology of inflammatory bowel disease , 2013, Clinical epidemiology.

[25]  N. Pedersen,et al.  East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort , 2013, Gut.

[26]  S. Riestra,et al.  P572 Changes of the smoking habit after diagnosis of Crohn's disease , 2013 .

[27]  M. Sans,et al.  Does Smoking Influence Crohn's Disease in the Biologic Era? The TABACROHN Study , 2013, Inflammatory bowel diseases.

[28]  E. Cabré,et al.  Impact of environmental and dietary factors on the course of inflammatory bowel disease. , 2012, World journal of gastroenterology.

[29]  G. Latella,et al.  Crucial steps in the natural history of inflammatory bowel disease. , 2012, World journal of gastroenterology.

[30]  L. Peyrin-Biroulet,et al.  Review article: the natural history of postoperative Crohn's disease recurrence , 2012, Alimentary pharmacology & therapeutics.

[31]  A. Keshavarzian,et al.  Is Moderate Red Wine Consumption Safe in Inactive Inflammatory Bowel Disease? , 2011, Digestion.

[32]  G. Mullin,et al.  Existing dietary guidelines for Crohn’s disease and ulcerative colitis , 2011, Expert review of gastroenterology & hepatology.

[33]  V. Fazio,et al.  Impact of smoking on disease phenotype and postoperative outcomes for Crohn’s disease patients undergoing surgery , 2011, Langenbeck's Archives of Surgery.

[34]  D. Ardid,et al.  Immunopathogenesis of inflammatory bowel disease. , 2010, Self/nonself.

[35]  L. Ferguson,et al.  Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand. , 2010, Mutation research.

[36]  P. Anand,et al.  Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain , 2010, Gut.

[37]  A. Keshavarzian,et al.  Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. , 2010, Alcohol.

[38]  J. Kolls,et al.  Alcohol and Health Focus On: Alcohol and the Immune System Overview of the Human Immune System Alcohol and Health Alcohol and Health Alcohol and the Innate Immune Response Alcohol and Health , 2022 .

[39]  R. Rao.  Endotoxemia and gut barrier dysfunction in alcoholic liver disease , 2009, Hepatology.

[40]  K. Kodys,et al.  The Opposite Effects of Acute and Chronic Alcohol on Lipopolysaccharide-Induced Inflammation Are Linked to IRAK-M in Human Monocytes1 , 2009, The Journal of Immunology.

[41]  P. Tekkis,et al.  The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies , 2008, International Journal of Colorectal Disease.

[42]  J. Mate,et al.  Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response. , 2007, Hepato-gastroenterology.

[43]  A. Basbaum,et al.  4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1 , 2007, Proceedings of the National Academy of Sciences.

[44]  A. Klatsky,et al.  Alcohol Drinking and Total Mortality Risk , 2007 .

[45]  A. Klatsky.  Alcohol, cardiovascular diseases and diabetes mellitus. , 2007, Pharmacological research.

[46]  H. Grønbæk,et al.  Effects of five different alcoholic drinks on patients with Crohn's disease , 2007, Scandinavian journal of gastroenterology.

[47]  C. Ley,et al.  Patients with crohn’s disease are unaware of the risks that smoking has on their disease , 2003, Journal of Gastrointestinal Surgery.

[48]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[49]  H. Mulcahy,et al.  Infliximab therapy in Crohn's disease: a pragmatic approach? , 2006, Alimentary pharmacology & therapeutics.

[50]  R. Sartor.  Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[51]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[52]  R. Ammann.  Diagnosis and management of chronic pancreatitis: current knowledge. , 2006, Swiss medical weekly.

[53]  M. Mrcp,et al.  Smoking, the oral contraceptive pill, and Crohn's disease , 2005, Digestive Diseases and Sciences.

[54]  U. Böcker,et al.  Inflammatory Bowel Disease and Smoking: A Review of Epidemiology, Pathophysiology, and Therapeutic Implications , 2004, Inflammatory bowel diseases.

[55]  M. Pearce,et al.  Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study , 2004, Gut.

[56]  Samir A. Shah,et al.  Smoking and Immunomodulators do not Influence the Response or Duration of Response to Infliximab in Crohn's Disease , 2004, Inflammatory bowel diseases.

[57]  Q. Zheng,et al.  Ethanol suppresses cytokine responses induced through Toll-like receptors as well as innate resistance to Escherichia coli in a mouse model for binge drinking. , 2004, Alcohol.

[58]  R. Rao,et al.  Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[59]  J. Satsangi,et al.  An analysis of factors influencing short‐term and sustained response to infliximab treatment for Crohn's disease , 2003, Alimentary pharmacology & therapeutics.

[60]  An Carbonez,et al.  Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. , 2003, The New England journal of medicine.

[61]  J. Achkar,et al.  Predictors of response to infliximab in patients with Crohn's disease. , 2002, Gastroenterology.

[62]  J. Belaiche,et al.  Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease , 2002, American Journal of Gastroenterology.

[63]  T. Klein,et al.  Involvement of Nicotinic Acetylcholine Receptors in Suppression of Antimicrobial Activity and Cytokine Responses of Alveolar Macrophages to Legionella pneumophila Infection by Nicotine1 , 2001, The Journal of Immunology.

[64]  F. Carbonnel,et al.  Impact of cessation of smoking on the course of ulcerative colitis , 2001, American Journal of Gastroenterology.

[65]  F. Carbonnel,et al.  Smoking cessation and the course of Crohn's disease: an intervention study. , 2001, Gastroenterology.

[66]  T. Chiba,et al.  Alcohol‐related diarrhea , 2000, Addiction biology.

[67]  H. Ishii,et al.  Effect of acute ethanol administration on the intestinal absorption of endotoxin in rats. , 2000, Alcoholism, clinical and experimental research.

[68]  F. Carrat,et al.  Effects of current and former cigarette smoking on the clinical course of Crohn’s disease , 1999, Alimentary pharmacology & therapeutics.

[69]  P. Mandrekar,et al.  Inhibition of lipopolysaccharide-mediated NFkappaB activation by ethanol in human monocytes. , 1999, International immunology.

[70]  C. Fiocchi.  Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[71]  A. Timmer,et al.  Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease ☆ ☆☆ , 1998 .

[72]  A. Timmer,et al.  Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. , 1998, Gastroenterology.

[73]  S. Targan,et al.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. , 1997, The New England journal of medicine.

[74]  F. Carbonnel,et al.  Effects of cigarette smoking on the long-term course of Crohn's disease. , 1996, Gastroenterology.

[75]  B. Huitfeldt,et al.  Smoking in Crohn's disease: effect on localisation and clinical course. , 1992, Gut.

[76]  A. Ahlbom,et al.  Inflammatory bowel disease and tobacco smoke--a case-control study. , 1990, Gut.

[77]  B. Calkins.  A meta-analysis of the role of smoking in inflammatory bowel disease , 1989, Digestive diseases and sciences.

[78]  R. Pounder,et al.  PATHOGENESIS OF CROHN'S DISEASE: MULTIFOCAL GASTROINTESTINAL INFARCTION , 1989, The Lancet.

[79]  T. Koepsell,et al.  Coffee and alcohol use and the risk of ulcerative colitis. , 1989, The American journal of gastroenterology.

[80]  T. Koepsell,et al.  Effects of cigarette smoking on the clinical course of ulcerative colitis. , 1988, Scandinavian journal of gastroenterology.

[81]  S. Shumak,et al.  Davidson's Principles and practice of medicine , 1988, The Ulster Medical Journal.

[82]  E. Lindberg,et al.  Smoking and inflammatory bowel disease. A case control study. , 1988, Gut.

[83]  C. Benoni,et al.  Smoking habits in patients with inflammatory bowel disease. A case-control study. , 1987, Scandinavian journal of gastroenterology.

[84]  D. Jewell,et al.  Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. , 1986, British medical journal.

[85]  M. World,et al.  Alcoholic malnutrition and the small intestine. , 1985, Alcohol and alcoholism.

[86]  J. F. Waller.  Davidson's Principles and Practice of Medicine , 1978 .